Bone Marrow Diseases clinical trials

The registry lists 66 studies for Bone Marrow Diseases across more than 10 countries. 12 are recruiting or about to start. 10 of them are mainly about Bone Marrow Diseases (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10. Counting its 28 narrower conditions too, such as Myelodysplastic Syndromes: 4,389 studies, 787 open.

Get an email when these change. Save the Bone Marrow Diseases studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies

See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed: 33
Terminated: 10
Recruiting: 8
Active, not recruiting: 5
Status unknown: 4
Not yet recruiting: 3

Phase

Phase 2: 24
Phase 3: 17
Phase 1: 14
Phase 4: 3

Where

United States: 35
France: 22
United Kingdom: 16
Germany: 16
Australia: 14
Canada: 13

Who runs them

Novartis Pharmaceuticals (7) · National Heart, Lung, and Blood Institute (NHLBI) (4) · Groupe Francophone des Myelodysplasies (3) · Ariad Pharmaceuticals (3) · Cellenkos, Inc. (2) · AOP Orphan Pharmaceuticals AG (2) · Shandong University (2) · Center for International Blood and Marrow Transplant Research (2)

Coming up

1phase 3 study under way

5studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 5

Dec 2026HLA-Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation With Reduced Dose Post Transplantation Cyclophosphamide GvHD Prophylaxis · Center for International Blood and Marrow Transplant Research
Apr 2027Leading in MPNs Beyond Ruxolitinib in Combo With T-Regs · Cellenkos, Inc.
May 2027A Clinical Trial of CK0801 (a New Drug) in Patients With Bone Marrow Failure Syndrome (BMF) · Cellenkos, Inc.
Oct 2027Myeloproliferative Neoplasms (MPNs) Patient Registry · University Health Network, Toronto
Nov 2027Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome · Orca Biosystems, Inc.

Who these studies take

Of the 8 Bone Marrow Diseases studies recruiting now, 6 (75%) set no upper age limit and 0 (0%) stop at 75 or younger. 3 (38%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.

Recruiting studies that take each age, of 8
Age	Women	Men
10	2 (25%)	2 (25%)
18	8 (100%)	8 (100%)
30	8 (100%)	8 (100%)
40	8 (100%)	8 (100%)
50	8 (100%)	8 (100%)
65	8 (100%)	8 (100%)
75	8 (100%)	8 (100%)
85	8 (100%)	8 (100%)

Across all 66 studies, recruiting or not: 14% stop at 75 or younger and 8% at 65; 20% take children; 2% are for women only and 0% for men only; 2% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

What changed recently

From the registry's own updates since Oct 13, 2026.

Newly registered1

Phase 2 Study of Oral Epetraborole in Adults With Polycythemia VeraOct 23, 2026NCT07891533

Studies

Recruiting first, then most recently updated. Showing 50 of 66. Browse all 66 → or search them.